| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 145 |
| 1 | METHOTREXATE SODIUM | 134 |
| 2 | CYTARABINE | 133 |
| 3 | ETOPOSIDE | 133 |
| 4 | PEGASPARGASE | 132 |
| 5 | DEXAMETHASONE | 131 |
| 6 | DEXAMETHASONE 1.5 MG | 131 |
| 7 | MERCAPTOPURINE | 130 |
| 8 | FILGRASTIM | 124 |
| 9 | METHYLPREDNISOLONE | 124 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DAUNORUBICIN HYDROCHLORIDE | 44 | 0.0267 |
| 1 | CHENODIOL | 4 | 0.0114 |
| 2 | PEGASPARGASE | 132 | 0.0107 |
| 3 | MERCAPTOPURINE | 130 | 0.0075 |
| 4 | FILGRASTIM | 124 | 0.0033 |
| 5 | VINCRISTINE SULFATE | 92 | 0.0031 |
| 6 | HYDROCORTISONE BUTYRATE | 6 | 0.0030 |
| 7 | CALCIUM FOLINATE | 14 | 0.0030 |
| 8 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | 1 | 0.0029 |
| 9 | MESNA INJECTION | 23 | 0.0028 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 160 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 135 |
| 2 | Topoisomerase Inhibitor [EPC] | 133 |
| 3 | Asparagine-specific Enzyme [EPC] | 132 |
| 4 | Leukocyte Growth Factor [EPC] | 124 |
| 5 | Alkylating Drug [EPC] | 117 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 117 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 20 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 7 |
| 9 | Calcium [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 132 | 0.0098 |
| 1 | Topoisomerase Inhibitor [EPC] | 133 | 0.0017 |
| 2 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 2 | 0.0011 |
| 4 | Leukocyte Growth Factor [EPC] | 124 | 0.0009 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 135 | 0.0005 |
| 6 | Alkylating Drug [EPC] | 117 | 0.0005 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 8 | Antisense Oligonucleotide [EPC] | 4 | 0.0003 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 4 | 0.0003 |